MAALKDQLIV NLLKEEQVPQ NKITVVGVGA VGMACAISIL MKDLADELALVDVIEDKLKG EMMDLQHGSL FLKTPKIVSS KDYSVTANSK LVIITAGARQ QEGESRLNLV QRNVNIFKFIIPNVVKYSPQ CKLLIVSNPV DILTYVAWKI SGFPKNRVIG SGCNLDSARF RYLMGERLGV HPLSCHGWVLGEHGDSSVPV WSGVNVAGVS LKSLNPQLGT DADKEQWKDV HKQVVDSAYE VIKLKGYTSW AIGLSVADLAESIMKNLRRV HPISTMIKGL YGIKEDVFLS VPCILGQNGI SDVVKVTLTP DEEARLKKSA DTLWGIQKEL QFLEHHHHHH

Voraussichtliches MW

37.5 kDa

Reinheit

>95% as determined by SDS-PAGE.

Produktform

Liquid

Konzentration

0.25mg/ml

Formulierung

Supplied in Phosphate Buffered Saline, pH 7.4, with 1 mM DTT and 20% Glycerol.

Lagerung

Shipped at 4°C. Short term (2-4 weeks) store at 4°C. Long term store at -20°C, it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid freeze/thaw cycles.

Synonyme

Cell proliferation inducing gene 19 protein, Cell proliferation-inducing gene 19 protein, Epididymis secretory protein Li 281, Epididymis secretory sperm binding protein Li 133P, GSD11, HEL S 133P, HEL S 281, L lactate dehydrogenase A chain, L lactate dehydrogenase B chain, L-lactate dehydrogenase A chain, Lactate dehydrogenase A, Lactate dehydrogenase B, Lactate dehydrogenase H chain, Lactate dehydrogenase M, LDH A, LDH B, LDH H, LDH heart subunit, LDH M, LDH muscle subunit, LDH-A, LDH-M, LDH1, LDHA, LDHA_HUMAN, LDHB, LDHBD, LDHM, MS1111, PIG19, Proliferation inducing gene 19, Renal carcinoma antigen NY REN 46, Renal carcinoma antigen NY REN 59, Renal carcinoma antigen NY-REN-59, TRG 5, TRG5

Haftungsausschluss

Dieses Produkt ist nur für Forschungszwecke bestimmt. Es ist nicht für diagnostische oder therapeutische Zwecke bestimmt.